The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
HADLIMA adalimumab (rch) 40 mg solution for injection in PushTouch auto-injector (284248)
ARTG Name
HADLIMA adalimumab (rch) 40 mg solution for injection in PushTouch auto-injector
Product name
HADLIMA adalimumab (rch) 40 mg solution for injection in PushTouch auto-injector
ARTG Date
Registration Type
Medicine
Therapeutic good type
Medicine
Sponsor
Ingredients
Adalimumab
Licence category
RE
Licence status
A
Summary
Product Information
Consumer Medicine Information